DOW JONES23,194.64+514.65 2.27%
S&P 5002,712.53+48.85 1.83%
NASDAQ8,023.55+110.32 1.39%

Evercore ISI Maintains Outperform, $126 Target On Medtronic As Firm Notes The American College Of Cardiology Late Breaker Agenda Implies Medtronic's Spyral Off-Med pivotal RCT Data 'trial hit superiority - a clear positive for MDT!'

Benzinga · 02/03/2020 18:21